Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126692) titled 'A Prospective Observational Clinical Study on the Efficacy and Safety of Domestic vs. Imported Oxycodone Hydrochloride Sustained-Release Tablets in the Treatment of Cancer Pain' on June 13.
Study Type: Observational study
Study Design:
Non randomized control
Primary Sponsor: Ningbo Medical Centre Lihuili Hospital
Condition:
Moderate to severe cancer pain
Intervention:
Ruianning Group:None
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-06-15
Target Sample Size: Ruianning Group:50;OxyContin group:50;
Countries of Recruitment:
China
To know more, visit https://www.chictr.or...